Vivani Medical Inc. logo

Vivani Medical Inc. (U5P)

Market Open
12 Jun, 15:02
XSTU XSTU
0. 97
+0.01
+0.5181%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.5 Eps
0.96
Previous Close
Add Transaction
Day Range
0.95 0.98
Year Range
0.8 1.55
Want to track U5P and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

U5P trading today higher at €0.97, an increase of 0.5181% from yesterday's close, completing a monthly decrease of -12.6126% or -€0.14. Over the past 12 months, U5P stock lost -5.8252%.
U5P is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0.1%. On average, the company has surpassed earnings expectations by 0.0617%, based on the last three reports.
Vivani Medical Inc. has completed 2 stock splits, with the recent split occurring on Aug 19, 2022.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

U5P Chart

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

Vivani Medical (VANI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 2 months ago
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Decreases By 25.4%

Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Decreases By 25.4%

Vivani Medical, Inc. (NASDAQ: VANI - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 27th, there was short interest totaling 290,597 shares, a decrease of 25.4% from the February 12th total of 389,363 shares. Approximately 0.7% of the company's stock are sold short. Based on an

Defenseworld | 2 months ago
Contrasting Vivani Medical (NASDAQ:VANI) & VYNE Therapeutics (NASDAQ:VYNE)

Contrasting Vivani Medical (NASDAQ:VANI) & VYNE Therapeutics (NASDAQ:VYNE)

VYNE Therapeutics (NASDAQ: VYNE - Get Free Report) and Vivani Medical (NASDAQ: VANI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Volatility and Risk VYNE Therapeutics has a

Defenseworld | 2 months ago

Vivani Medical Inc. (U5P) FAQ

What is the stock price today?

The current price is €0.97.

On which exchange is it traded?

Vivani Medical Inc. is listed on XSTU.

What is its stock symbol?

The ticker symbol is U5P.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Vivani Medical Inc. ever had a stock split?

Vivani Medical Inc. had 2 splits and the recent split was on Aug 19, 2022.

Vivani Medical Inc. Profile

Health Care Technology Industry
Healthcare Sector
Adam Mendelsohn CEO
XSTU Exchange
US92854B1098 ISIN
US Country
37 Employees
- Last Dividend
19 Aug 2022 Last Split
19 Nov 2014 IPO Date

Overview

Vivani Medical, Inc. stands as a clinical-stage enterprise committed to the innovation of medical solutions designed to address chronic diseases that currently suffer from a high degree of unmet medical needs. Positioned at the forefront of medical technology, Vivani Medical is dedicated to transforming the treatment landscape for these conditions. With its headquarters nestled in Emeryville, California, the company signifies a hub of innovation aimed at redefining the standards of patient care through groundbreaking medical devices.

Products and Services

  • Miniature Drug Implants:

    Vivani Medical is pioneering the development of a portfolio of miniature drug implants. These implants are ingeniously designed to deliver drugs into the body with minimal fluctuations in dose. This cutting-edge approach ensures a more consistent delivery of medication, targeting chronic diseases with precision and improving the overall effectiveness of treatment regimens. The focus is on enhancing patient convenience and compliance, significantly impacting long-term disease management.

  • Implantable Visual Prostheses Devices:

    In a bold venture into the realm of visual impairment, Vivani Medical is developing implantable visual prostheses devices. These devices herald a new era in artificial vision, offering a beacon of hope for blind individuals. By providing a form of useful artificial vision, these prostheses aim to significantly enhance the quality of life for those affected by blindness. The innovation encapsulates the company's dedication to tackling conditions with substantial unmet needs, offering groundbreaking solutions that extend beyond the conventional treatment paradigms.

Contact Information

Address: 5858 Horton Street
Phone: 818 833 5000